Idenix Pharmaceuticals (IDIX) Posts Q4 Loss of 18c/Sh., Wider than Views

February 23, 2012 4:14 PM EST
Get Alerts IDIX Hot Sheet
Trade IDIX Now!
Join SI Premium – FREE
Idenix Pharmaceuticals (NASDAQ: IDIX) reported Q4 EPS of ($0.18), $0.04 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Idenix Pharmaceuticals (IDIX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment